In a secondary transplant, mice receiving bone marrow cells from donors that had been inoculated with R406-pretreated AMLs cells showed a trend to a reduced leukemia burden (Supplementary Fig.
← all excerpts
SYK inhibition targets acute myeloid leukemia stem cells by blocking their oxidative metabolism.
1
—
—